ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGN Allergan plc

193.02
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Allergan plc NYSE:AGN NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 193.02 0 01:00:00

Allergan to Present at the Jefferies 2019 Healthcare Conference

23/05/2019 12:30pm

PR Newswire (US)


Allergan (NYSE:AGN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Allergan Charts.

DUBLIN, May 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Commercial Officer William Meury will participate in a fireside chat at the Jefferies 2019 Healthcare Conference in New York, NY. The presentation will begin at 2:00 p.m. Eastern Time on Thursday, June 6, 2019.

Allergan plc logo

The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at https://www.allergan.com/investors/events-presentations. The webcast can also be accessed through the following URL: http://wsw.com/webcast/jeff118/register.aspx?conf=jeff118&page=agn&url=http://wsw.com/webcast/jeff118/agn/index.aspx

An archived version will be available following the live presentation and can be accessed at the same location for 90 days.

About Allergan plc

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry.

With colleagues and commercial operations located in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.

For more information, visit Allergan's website at www.Allergan.com.

CONTACTS:
Allergan:
Investors:
Manisha Narasimhan, PhD
(862) 261-7162

Christine Chiou
(862) 261-7396

Media:
Amy Rose
(862) 289-3072

Lisa Brown
(862) 261-7320

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/allergan-to-present-at-the-jefferies-2019-healthcare-conference-300855485.html

SOURCE Allergan plc

Copyright 2019 PR Newswire

1 Year Allergan Chart

1 Year Allergan Chart

1 Month Allergan Chart

1 Month Allergan Chart

Your Recent History

Delayed Upgrade Clock